CClinicalTrials.gg
Enrolling by invitationNCT06241859Updated Mar 15, 2024

The Impact of Sedation Depth Monitoring for Cognitive Functions and Early Rehabilitation After Major Joints Arthroplasty

An interventional study of Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland) and Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland) in Total Knee Replacement Surgery, sponsored by Lithuanian University of Health Sciences. Enrolling by invitation at 1 site in Lithuania. Open to participants aged 66 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-03-15.

Sponsored by Lithuanian University of Health Sciences · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 6 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
66 Years to 90 Years
Sex
All
01

Study summary

Spinal anesthesia is applied for patients undergoing total elective knee replacement surgery. It reduces rates of postoperative complications, improves postoperative pain management, rehabilitation is started earlier and patients more quickly return to the rhythm of ordinary life. According to the literature data, perioperative stress impacts part of cardiovascular complications and exacerbates postoperative pain. It is important that patients during the surgery under spinal anesthesia prefer to sleep. Thus, in order to reduce perioperative stress, patients during surgery are sedated. It is one of the most effective methods.

On the other hand, deep sedation during surgery versus light sedation, is related to more frequent postoperative cognitive impairment and delirium. It leads to worse later surgery results and worse postoperative quality of life, increased risk of falling, prolonged duration of hospitalization, increased expenses.

Read the detailed description

The aim: To determine value of sedation depth monitoring in order to save patients cognitive functions, to reduce incidence of postoperative delirium and to improve quality of early rehabilitation after the elective total elective knee replacement surgery.

Primary hypothesis: targeted sedation depth monitoring, in order to support light sedation level during the elective knee arthroplasty, helps to save cognitive function and reduce incident of postoperative delirium.

Secondary hypothesis: targeted sedation depth monitoring, in order to support light sedation level, provide better ability to early rehabilitation and patients more quickly return to the rhythm of ordinary life after elective total knee arthroplasty.

Objectives:

  1. To evaluate moderate and deep sedation rates in a group of patients sedated according to clinical signs only.
  2. To compare changes in cognitive functions and incidence of delirium after the surgery between a group of patients with light sedation according to bispectral index (BIS) and a group of patients sedated according to clinical signs.
  3. To assess the impact of sedation depth monitoring for ability and quality of early rehabilitation after elective total knee replacement surgery.

Methods:

The prospective, randomized, double-blinded study includes American Society of Anesthesiologists (ASA) physical status I-II patients in preoperative assessment, aged >65 years, admitted for the elective total knee arthroplasty under spinal anesthesia with sedation. Preoperatively patients will be blindly randomized into one of two groups. Experimental group: light sedation according to BIS and control group: sedation according to clinical signs. Group assignment will be concealed by opaque envelopes that will be opened only after enrolment. The investigator, who does not interview patients, will document which group the participant belongs to and will provide an unique number. The same investigator will collect data in an operating room. But the participant and outcomes assessor will be blinded to group assignment.

During the perioperative period all patients from both groups will receive a standardized anesthetic and analgesic. Premedication of midazolam 2.5 mg will be given to all patients and a slow fluid infusion of crystalloids will be started once as an intravenous cannula will be placed. Spinal anesthesia after identification of the subarachnoid space will be performed with 15 mg of levobupivacaine. After that, for post operative analgesia femoral triangle and adductor canal blocks will be performed under the ultrasound guidance. Patients will be sedated with intravenously administered propofol according to BIS, in order to support light sedation level (BIS value 80-90), or according to clinical sign (depending on the group of patients) during the surgery. During the surgery BIS and standard monitoring will be performed in both groups. After the surgery patients will be transferred to the post-anesthesia care unit (PACU). During the postoperative period NSAIDs and acetaminophen will be available in both groups.

Patients cognitive function will be evaluated before the surgery and at 2, 30, 90 postoperative days using Addenbrooke's Cognitive Examination test - revised (ACE-R). This is 100-scores test that allows to assess the main six cognitive function domains and weighted as follows: orientation (10), attention (8), memory (26), verbal fluency (14), language (26) and visuospatial ability (16).

The ability and quality of rehabilitation will be assessed before the surgery and at 2, 30, 90 days after the surgery using Quality of Life Questionnaire (SF-36v2 Health Survey). This test allows to assess the main eight quality of life domains: vitality, physical functioning, bodily pain, general health perceptions, role limitations due to physical and emotional health, social rule functioning, mental health.

Patients emotional state will be evaluated using the Geriatric Depression Scale before the surgery and at 2, 30, 90 postoperative days.

02

Conditions studied

  • Total Knee Replacement Surgery

Keywords

  • Sedation depth
  • Cognitive functions
  • Quality of rehabilitation
  • Functional recovery
  • Elective surgery
  • Total knee arthroplasty
03

In context

Lead sponsor

Lithuanian University of Health Sciences is the lead sponsor of 102 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
66 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients undergoing elective total knee replacement surgery under spinal anesthesia with sedation;
  • Age 66 - 90 years;
  • Patients conformed to American Society of Anesthesiologists (ASA) physical status I-II in preoperative assessment;
  • Ability to follow study protocol;
  • Signed agreement to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Refused elective total knee arthroplasty under spinal anesthesia with sedation;
  • Younger than 66 years;
  • Patients conformed to American Society of Anesthesiologists (ASA) physical status III-IV in preoperative assessment;
  • Patients with mental and central nervous system disorders, which hinder the perception and correct assessment of their condition;
  • Hearing, visual, speech disorders and inability to read, write;
  • Inability to understand and read in Lithuanian language;
  • Refusal to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Light sedation according to BIS

    Sedation depth will be monitored according to BIS.

    Device: Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland)

  • Sham comparator
    Sedation according to clinical signs

    Sedation depth will be monitored according to clinical signs using RASS scale, which aim is -3.

    Device: Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland)

Interventions

  • DeviceDräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland)

    Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland) will be used to maintain a sedation depth between 80-90 value, which corresponds to light sedation definition.

  • DeviceDräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland)

    Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland) will be used to monitor sedation depth.

06

What researchers measure

Primary outcomes

  1. Changes in cognitive function using Addenbrooke's Cognitive Examination test

    Time frame: Before the surgery and first 3 months after elective total knee arthroplasty

Secondary outcomes

  1. Quality of functional recovery using the Quality of Life Questionnaire (SF-36v2 Health Survey)

    Time frame: Before the surgery and first 3 months after elective total knee arthroplasty

  2. Rates of moderate and deep sedation according to the BIS in non-interventional group

    Time frame: During the surgery

  3. Changes in emotional state according to geriatric depression scale

    Time frame: Before the surgery and first 3 months after elective total knee arthroplasty

07

Study locations

1 site
  • Lithuanian University of Health Sciences Kaunas Clinics, Department of Anesthesiology
    Kaunas, Lithuania
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06241859
Lead sponsor
Lithuanian University of Health Sciences
Responsible party
Inna Jaremko, MD (Principal investigator, Lithuanian University of Health Sciences) — Principal investigator
First posted
Feb 5, 2024
Start date
Feb 10, 2024
Primary completion
Apr 2024 (estimated)
Completion
Jan 2025 (estimated)
Last update
Mar 15, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion